Two Sigma Securities’s Amicus Therapeutics FOLD Stock Holding History

Two Sigma Securities’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,955	Closed	-$173K	–	1957
2026 Q1	$173K	Buy	+11,955	New	+$171K	0.02%	1078
2025 Q4	–	Sell	-10,848	Closed	-$85.5K	–	1655
2025 Q3	$85.5K	Buy	+10,848	New	+$77.2K	0.01%	927
2025 Q2	–	Sell	-10,021	Closed	-$81.8K	–	1691
2025 Q1	$81.8K	Buy	+10,021	New	+$92.7K	0.01%	954
2024 Q4	–	Sell	-13,439	Closed	-$144K	–	2214
2024 Q3	$144K	Buy	+13,439	New	+$146K	﹤0.01%	2219
2023 Q2	–	Sell	-12,729	Closed	-$141K	–	2965
2023 Q1	$141K	Buy	+12,729	New	+$157K	﹤0.01%	2150
2017 Q3	–	Sell	-11,539	Closed	-$116K	–	1009
2017 Q2	$116K	Buy	+11,539	New	+$92.8K	0.02%	638

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Two Sigma Securities's FOLD Position: Q2 2026 in Review

Two Sigma Securities sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 11,955 shares — an estimated $173K sold.

Two Sigma Securities first reported a position in FOLD in Q2 2017 and held it in 6 quarters. The position peaked at $173K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Two Sigma Securities reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 11,955 Amicus Therapeutics shares in Q2 2026, an estimated $173K.
Two Sigma Securities first reported a position in Amicus Therapeutics in Q2 2017 and held it in 6 quarters.
Two Sigma Securities's Amicus Therapeutics position peaked at $173K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.